Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism.
about
An autoregulatory feedback loop between Mdm2 and SHP that fine tunes Mdm2 and SHP stabilityMultiple roles of Nrf2-Keap1 signaling: regulation of development and xenobiotic response using distinct mechanismsTranscript profiling identifies dynamic gene expression patterns and an important role for Nrf2/Keap1 pathway in the developing mouse esophagusNrf2 and the promotion of atherosclerosis: lessons to be learnedNFE2L2 polymorphisms, mortality, and metabolism in the general population.NF-E2-related factor 1 (Nrf1) serves as a novel regulator of hepatic lipid metabolism through regulation of the Lipin1 and PGC-1β genesCross-regulation of protein stability by p53 and nuclear receptor SHP.Characterization of the mitochondrial localization of the nuclear receptor SHP and regulation of its subcellular distribution by interaction with Bcl2 and HNF4α.Deficiency in Nrf2 transcription factor decreases adipose tissue mass and hepatic lipid accumulation in leptin-deficient miceNrf2 is essential for timely M phase entry of replicating hepatocytes during liver regeneration.Nuclear receptor SHP inhibition of Dnmt1 expression via ERRγ.Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice.Myeloid deletion of nuclear factor erythroid 2-related factor 2 increases atherosclerosis and liver injury.Nuclear factor-E2-related factor 2 is a major determinant of bile acid homeostasis in the liver and intestine.Zinc-induced Dnmt1 expression involves antagonism between MTF-1 and nuclear receptor SHP.Heme oxygenase-1, oxidation, inflammation, and atherosclerosisNuclear Factor Erythroid 2-Related Factor 2 Drives Podocyte-Specific Expression of Peroxisome Proliferator-Activated Receptor γ Essential for Resistance to Crescentic GNNew player on an old field; the keap1/Nrf2 pathway as a target for treatment of type 2 diabetes and metabolic syndrome.Pregnancy represses induction of efflux transporters in livers of type I diabetic mice.Nrf2 participates in regulating maternal hepatic adaptations to pregnancyHepatic gene expression profiling in Nrf2 knockout mice after long-term high-fat diet-induced obesityNuclear Factor Erythroid 2-Related Factor 2 Deficiency Results in Amplification of the Liver Fat-Lowering Effect of Estrogen.Genome-wide transcriptome analysis identifies novel gene signatures implicated in human chronic liver diseaseKeap1 knockdown increases markers of metabolic syndrome after long-term high fat diet feedingPigs fed camelina meal increase hepatic gene expression of cytochrome 8b1, aldehyde dehydrogenase, and thiosulfate transferase.Nuclear factor (erythroid-derived 2)-like 2 activation-induced hepatic very-low-density lipoprotein receptor overexpression in response to oxidative stress contributes to alcoholic liver disease in mice.Molecular mechanisms of hypolipidemic effects of curcumin.The role of the Nrf2/Keap1 pathway in obesity and metabolic syndrome.The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism.Flavonoids as Putative Inducers of the Transcription Factors Nrf2, FoxO, and PPARγCurcumin attenuates ethanol-induced hepatic steatosis through modulating Nrf2/FXR signaling in hepatocytes.Circadian clock control of hepatic lipid metabolism: role of small heterodimer partner (Shp).Protein phosphatase 2A (PP2A)-specific ubiquitin ligase MID1 is a sequence-dependent regulator of translation efficiency controlling 3-phosphoinositide-dependent protein kinase-1 (PDPK-1).Role of nuclear factor (erythroid-derived 2)-like 2 in metabolic homeostasis and insulin action: A novel opportunity for diabetes treatment?Collaborative Power of Nrf2 and PPARγ Activators against Metabolic and Drug-Induced Oxidative InjuryPerspectives of the Nrf-2 signaling pathway in cancer progression and therapy.Role of Nrf2 in the alteration of cholesterol and bile acid metabolism-related gene expression by dietary cholesterol in high fat-fed mice.PPARγ and Oxidative Stress: Con(β) Catenating NRF2 and FOXOQuercetin ameliorates dysregulation of lipid metabolism genes via the PI3K/AKT pathway in a diet-induced mouse model of nonalcoholic fatty liver disease.Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.
P2860
Q24319986-16EFEDC7-F8A1-4154-8356-05EE7DBA995AQ28383318-69685795-0710-4751-9346-7D2C86E90DCAQ28730162-48A41FEF-54B9-4A05-9DDB-4308D6B48949Q29541148-9EED9A60-32D3-4C2F-B580-BBA70B87A0B2Q33764879-14336CA7-8BEE-4F23-9E4B-525A52AFE092Q34274999-5EECDF2A-D158-4242-9C63-1FE995EF99D6Q34318481-302AF4FC-01D6-481B-AB06-F3F233F19366Q34848920-229AB612-373C-43BD-888B-5534668CC34FQ35027768-F1FE8815-E9B1-4F6F-AF09-21A8912347ADQ35086408-75DDE756-FB1E-4B0F-8C32-58B6C1810D74Q35099502-C45EA97F-C235-4096-956B-2B213096D2BCQ35790318-3A1B9E45-9995-4163-ADA7-BBF969DAA895Q35815261-4543CA67-CB57-42AB-B58D-18D0D1A1C24AQ35993987-6606F8FE-D828-441F-A087-A1B5695C7FEDQ36008156-AC0F015F-DF32-40DF-AD40-71CCBE6AF432Q36103851-CC6AC17F-DE94-47BE-B511-0939C7F44689Q36417899-9FFF3E46-8F89-471F-BB4C-E2C15BA058CCQ36695768-05CED017-8595-47A0-9550-796F5952ECB6Q36816962-44C00549-1F2A-47A2-9B1C-C306B724BD0DQ36825239-0BF13498-A657-4501-9DF2-68A6698DBD39Q36845143-21EE18B5-23E9-400F-B678-AC78DD3BED8FQ37062567-AD7FA76D-3601-43BE-9A74-11788B14A51DQ37142600-C2BA1976-B98B-4B2C-8253-334F736E8989Q37231144-3F504F22-1EC8-4A37-9267-9789297EAF6AQ37514068-90156391-0CCF-4275-8774-091469E9CD66Q37666136-BC8CB891-A8CC-4658-BC80-AECB53767057Q38075862-3B13DF6D-2BC2-49A5-AB77-AC8D256178D9Q38300447-C9A8B6AC-C8DC-4208-8556-B9046E23727FQ38539752-8D430DA5-5A11-4E97-BCDC-446D8E74DFFBQ38650433-7F3589E4-8805-4ABE-B383-ACD5D0BC0FC9Q38840947-50EE4CCA-07FD-4D19-B300-09D0E1CEEABDQ38912884-207ACFF2-61D8-4E72-B60D-EED10FE010DBQ39246100-23853038-0F77-4EF2-AF9A-FB107BBDB42FQ40408497-57A0CAC7-5916-44E2-889B-569F69AB44FAQ41449206-11E14ABC-5852-432D-B6F2-BCEBEE55AFCAQ41678966-B84C9718-5D91-4D42-B5A2-9D75D450A3CEQ42416040-C5824852-4DF4-4E51-AD12-B3C69623B2C0Q42560760-8A6CF3D8-D080-4F1F-B514-B4DE41DE37F1Q42702473-DC1B442A-9AAA-446F-A2C6-2BD924549051Q44874088-C6FAE4E1-D658-4AE3-9A92-A05333C0709E
P2860
Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Transcription factor Nrf2 regu ...... n in hepatic lipid metabolism.
@ast
Transcription factor Nrf2 regu ...... n in hepatic lipid metabolism.
@en
Transcription factor Nrf2 regu ...... n in hepatic lipid metabolism.
@nl
type
label
Transcription factor Nrf2 regu ...... n in hepatic lipid metabolism.
@ast
Transcription factor Nrf2 regu ...... n in hepatic lipid metabolism.
@en
Transcription factor Nrf2 regu ...... n in hepatic lipid metabolism.
@nl
prefLabel
Transcription factor Nrf2 regu ...... n in hepatic lipid metabolism.
@ast
Transcription factor Nrf2 regu ...... n in hepatic lipid metabolism.
@en
Transcription factor Nrf2 regu ...... n in hepatic lipid metabolism.
@nl
P2093
P2860
P356
P1476
Transcription factor Nrf2 regu ...... n in hepatic lipid metabolism.
@en
P2093
Imene Tabbi-Anneni
Jiansheng Huang
Viswanath Gunda
P2860
P304
P356
10.1152/AJPGI.00322.2010
P577
2010-10-07T00:00:00Z